| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
FTRE
Fortrea Holdings Inc.
|
Oct 30, 2026 | BUY |
Buy
+8.3% avg upside
13 analysts
|
$26.00
22.21% Upside
|
-5.1% | Β· |
|
ILMN
Illumina
|
Oct 30, 2026 | SELL |
Strong Buy
-10.1% avg upside
32 analysts
|
$200.00
15.27% Downside
|
+12.3% | Β· |
|
WST
West Pharmaceutical Services
|
Oct 30, 2026 | BUY |
Strong Buy
-6.0% avg upside
18 analysts
|
$500.00
21.14% Upside
|
+1.0% | Β· |
|
AVTR
Avantor
|
Oct 29, 2026 | SELL |
Buy
+4.5% avg upside
27 analysts
|
$16.00
0.33% Downside
|
+6.1% | Β· |
|
IQV
IQVIA Holdings
|
Oct 28, 2026 | BUY |
Strong Buy
-2.5% avg upside
40 analysts
|
$300.00
12.13% Upside
|
-5.0% | Β· |
|
ICLR
Icon
|
Oct 28, 2026 | HOLD |
Strong Buy
-1.8% avg upside
28 analysts
|
$175.00
17.30% Downside
|
-9.1% | Β· |
|
LH
Labcorp Holdings
|
Oct 28, 2026 | HOLD |
Strong Buy
-21.6% avg upside
38 analysts
|
$380.00
5.05% Upside
|
+3.3% | Β· |
|
RGEN
Repligen
|
Oct 28, 2026 | BUY |
Strong Buy
+1.3% avg upside
25 analysts
|
$225.00
27.23% Upside
|
-3.1% | Β· |
|
QGEN
Qiagen
|
Oct 27, 2026 | HOLD |
Buy
-10.5% avg upside
25 analysts
|
$53.00
5.45% Upside
|
-0.6% | Β· |
|
MEDP
Medpace Holdings
|
Oct 23, 2026 | HOLD |
Buy
-17.3% avg upside
18 analysts
|
$675.00
3.50% Upside
|
-2.3% | Β· |
|
DGX
Quest Diagnostics
|
Oct 23, 2026 | BUY |
Buy
-26.4% avg upside
34 analysts
|
$260.00
3.19% Upside
|
+6.8% | Β· |
|
DHR
Danaher
|
Oct 22, 2026 | BUY |
Strong Buy
-4.4% avg upside
47 analysts
|
$260.00
11.97% Upside
|
+1.4% | Β· |
|
TMO
Thermo Fisher
|
Oct 22, 2026 | BUY |
Strong Buy
-5.1% avg upside
40 analysts
|
$775.00
11.15% Upside
|
+3.5% | Β· |
|
CERT
Certara
|
Oct 07, 2026 | HOLD |
Buy
+21.4% avg upside
23 analysts
|
$9.00
18.35% Downside
|
+29.1% | Β· |
|
A
Agilent
|
Oct 07, 2026 | BUY |
Strong Buy
-8.0% avg upside
35 analysts
|
$195.00
11.45% Upside
|
+2.9% | Β· |
|
BRKR
Bruker
|
Oct 07, 2026 | BUY |
Buy
+4.9% avg upside
22 analysts
|
$70.00
22.62% Upside
|
+3.1% | Β· |
|
MTD
Mettler-Toledo
|
Oct 07, 2026 | BUY |
Buy
-26.0% avg upside
19 analysts
|
$1700.00
1.56% Upside
|
+12.9% | Β· |
|
PACB
Pacific Biosciences
|
Oct 07, 2026 | SELL |
Buy
+73.8% avg upside
14 analysts
|
$1.25
52.10% Downside
|
+27.9% | Β· |
|
RVTY
Revvity
|
Oct 07, 2026 | HOLD |
Buy
-19.9% avg upside
25 analysts
|
$160.00
1.87% Upside
|
+3.1% | Β· |
|
WAT
Waters
|
Oct 07, 2026 | BUY |
Strong Buy
-12.6% avg upside
31 analysts
|
$500.00
8.07% Upside
|
+5.6% | Β· |
|
NTRA
Natera
|
Oct 07, 2026 | BUY |
Strong Buy
-13.3% avg upside
28 analysts
|
$475.00
14.67% Upside
|
-19.3% | Β· |
|
GH
Guardant Health
|
Oct 07, 2026 | BUY |
Strong Buy
-3.1% avg upside
33 analysts
|
$220.00
23.10% Upside
|
-9.9% | Β· |
|
TWST
Twist Bioscience
|
Oct 07, 2026 | BUY |
Strong Buy
-19.2% avg upside
16 analysts
|
$215.00
40.69% Upside
|
-28.3% | Β· |
|
TXG
10x Genomics
|
Oct 07, 2026 | BUY |
Buy
-7.5% avg upside
19 analysts
|
$110.00
56.82% Upside
|
-23.5% | Β· |
|
SHC
Sotera Health
|
Oct 07, 2026 | BUY |
Strong Buy
+20.0% avg upside
13 analysts
|
$22.00
21.26% Upside
|
-7.2% | Β· |
|
CRL
Charles River Labs
|
Sep 24, 2026 | BUY |
Strong Buy
-28.5% avg upside
36 analysts
|
$330.00
8.26% Downside
|
+14.3% | Β· |
|
LUMN
Lumen Technologies
|
Jun 12, 2023 | HOLD |
Sell
+120.1% avg upside
21 analysts
|
$42.00
760.58% Upside
|
-32.8% | Β· |
|
JBHT
JB Hunt
|
Jan 18, 2023 | BUY |
Strong Buy
+16.7% avg upside
33 analysts
|
$200.00
9.50% Downside
|
+7.4% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.